Omnicell Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Omnicell kazanç ve gelirinin sırasıyla yıllık 28.4% ve 3.7% oranında artması tahmin edilirken, EPS'nin yıllık 27.5% oranında büyümesi bekleniyor.

Anahtar bilgiler

28.4%

Kazanç büyüme oranı

27.53%

EPS büyüme oranı

Medical Equipment kazanç büyümesi	13.8%
Gelir büyüme oranı	3.7%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Good
Son güncelleme	31 Oct 2025

Gelecekteki son büyüme güncellemeleri

Recent updates

Omnicell Q2 Earnings: Market Ignoring The Segments

Jul 31

Omnicell (NASDAQ:OMCL) May Have Issues Allocating Its Capital

Jul 16

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Jun 28

Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges

May 27 Supply chain improvements and near-shoring are expected to offset cost pressures, while a shift to recurring SaaS and services enhances earnings stability and valuation potential.

It Looks Like Omnicell, Inc.'s (NASDAQ:OMCL) CEO May Expect Their Salary To Be Put Under The Microscope

May 14

US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results

May 09

Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 09

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 26% Below Their Intrinsic Value Estimate

Jan 28

Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues

Nov 27

Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next

Nov 02

Omnicell Q3 Earnings: Look At The Growth Segment

Nov 01

Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Oct 31

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Oct 07

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Aug 02

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Jul 11

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Jun 16

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

May 25

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Feb 23

Omnicell Is Building A Strong Moat

Feb 22

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Jan 15

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Dec 25

Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Dec 06

Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Nov 10

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Sep 06

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:OMCL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2027	1,278	32	63	N/A	4
12/31/2026	1,227	21	47	N/A	8
12/31/2025	1,184	11	38	N/A	7
9/30/2025	1,178	20	94	153	N/A
6/30/2025	1,150	23	89	148	N/A
3/31/2025	1,136	21	108	164	N/A
12/31/2024	1,112	13	135	188	N/A
9/30/2024	1,064	-18	118	170	N/A
6/30/2024	1,080	-21	152	204	N/A
3/31/2024	1,103	-21	165	218	N/A
12/31/2023	1,147	-20	126	181	N/A
9/30/2023	1,186	-34	165	225	N/A
6/30/2023	1,235	-23	127	189	N/A
3/31/2023	1,268	-18	48	107	N/A
12/31/2022	1,296	6	17	78	N/A
9/30/2022	1,309	48	-5	55	N/A
6/30/2022	1,258	61	18	77	N/A
3/31/2022	1,199	72	98	158	N/A
12/31/2021	1,132	78	173	232	N/A
9/30/2021	1,070	80	195	249	N/A
6/30/2021	987	60	194	242	N/A
3/31/2021	914	35	164	218	N/A
12/31/2020	892	32	131	186	N/A
9/30/2020	891	38	86	144	N/A
6/30/2020	906	49	101	164	N/A
3/31/2020	924	69	85	144	N/A
12/31/2019	897	61	83	145	N/A
9/30/2019	860	54	98	158	N/A
6/30/2019	836	48	N/A	117	N/A
3/31/2019	807	38	N/A	112	N/A
12/31/2018	787	38	N/A	104	N/A
9/30/2018	772	54	N/A	61	N/A
6/30/2018	754	48	N/A	27	N/A
3/31/2018	747	44	N/A	16	N/A
12/31/2017	713	31	N/A	25	N/A
9/30/2017	688	-1	N/A	45	N/A
6/30/2017	678	-6	N/A	72	N/A
3/31/2017	670	-9	N/A	56	N/A
12/31/2016	696	10	N/A	50	N/A
9/30/2016	651	8	N/A	54	N/A
6/30/2016	599	14	N/A	40	N/A
3/31/2016	539	24	N/A	44	N/A
12/31/2015	485	31	N/A	38	N/A
9/30/2015	476	32	N/A	37	N/A
6/30/2015	463	32	N/A	50	N/A
3/31/2015	455	31	N/A	75	N/A
12/31/2014	441	31	N/A	65	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: OMCL 'nin tahmini kazanç büyümesi (yıllık 28.4% ) tasarruf oranının ( 3.1% ) üzerindedir.

Kazançlar ve Piyasa: OMCL şirketinin kazançlarının (yıllık 28.4% ) US pazarından (yıllık 16.1% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: OMCL şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: OMCL şirketinin gelirinin (yıllık 3.7% ) US pazarından (yıllık 10.4% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: OMCL şirketinin gelirinin (yıllık 3.7% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: OMCL 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/11/02 17:20
Gün Sonu Hisse Fiyatı	2025/10/31 00:00
Kazançlar	2025/09/30
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Omnicell, Inc. 21 Bu analistlerden 8, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Raymond Myers	Benchmark Company
William Sutherland	Benchmark Company
Zhilin Long	Berenberg

Omnicell Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Omnicell, Inc. Updates Earnings Guidance for the Full Year 2025

Consensus EPS estimates have been upgraded.

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Updated Full Year 2025

Consensus EPS estimates upgraded to US$0.04 loss

Consensus EPS estimates upgraded to US$0.0025 loss

Consensus EPS estimates upgraded to US$0.10 loss

Recent updates

Third quarter 2025 earnings: EPS and revenues exceed analyst expectations

Omnicell, Inc. Updates Earnings Guidance for the Full Year 2025

Omnicell, Inc. to Report Q3, 2025 Results on Oct 30, 2025

Now 20% undervalued

Omnicell, Inc. Appoints Baird Radford as Chief Financial Officer, Effective August 26, 2025

Consensus EPS estimates have been upgraded.

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Omnicell Q2 Earnings: Market Ignoring The Segments

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Updated Full Year 2025

Consensus EPS estimates upgraded to US$0.04 loss

Omnicell (NASDAQ:OMCL) May Have Issues Allocating Its Capital

Omnicell, Inc. to Report Q2, 2025 Results on Jul 31, 2025

Consensus EPS estimates upgraded to US$0.0025 loss

Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 2000 Value-Defensive Index

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges

Consensus EPS estimates upgraded to US$0.10 loss

Price target increased by 7.2% to US$39.83

Omnicell, Inc. (NasdaqGS:OMCL) announces an Equity Buyback for $75 million worth of its shares.

Omnicell, Inc. Announces New Products Designed to Streamline Workflows and Enhance Inventory Visibility and Management in Perioperative and Clinic Settings

Investor sentiment improves as stock rises 17%

It Looks Like Omnicell, Inc.'s (NASDAQ:OMCL) CEO May Expect Their Salary To Be Put Under The Microscope

US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results

Now 21% undervalued after recent price drop

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Omnicell, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2025

Omnicell, Inc. to Report Q1, 2025 Results on May 06, 2025

Omnicell (NASDAQ:OMCL) Seems To Use Debt Rather Sparingly

Omnicell, Inc., Annual General Meeting, May 21, 2025

Omnicell, Inc. Appoints Perry A. Genova as Senior Vice President, Chief Technology Officer, Effective March 31, 2025

Founder recently bought US$350k worth of stock

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025

Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem

Omnicell Q4 Earnings: Ignore The Short-Term Noise

Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

New minor risk - Earnings quality

Full year 2024 earnings: EPS exceeds analyst expectations

Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year of 2025

Omnicell, Inc. (NASDAQ:OMCL) Shares Could Be 26% Below Their Intrinsic Value Estimate

Omnicell, Inc. to Report Q4, 2024 Results on Feb 06, 2025

Independent Director recently sold US$568k worth of stock

Independent Director notifies of intention to sell stock

Omnicell, Inc. Announces OmniSphere

Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues

Now 22% undervalued after recent price drop

Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next

Omnicell, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024

Omnicell Q3 Earnings: Look At The Growth Segment

Price target increased by 22% to US$54.71

Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Price target increased by 7.5% to US$45.00

Omnicell, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Omnicell, Inc. Announces Central Med Automation Service

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 17% to US$38.29

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024

Omnicell, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Now 20% undervalued

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Omnicell, Inc. Announces XT Amplify

Omnicell, Inc. to Report Q1, 2024 Results on May 02, 2024

Omnicell, Inc., Annual General Meeting, May 21, 2024

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued